The Asco Post

Today in Oncology

Current News from the World of Oncology Last Updated: Wednesday, May 27, 2015 9:02:27 AM

Featured Columnists

Illumination and Innovation: Transforming Data Into Learning Peter P. Yu, MD, FASCO  

In Search of Meaning: A Personal Journey William Breitbart, MD  

Creating a Collective Path Forward to Optimize Value in Cancer Care Richard L. Schilsky, MD, FACP, FASCO  

More Featured Columnists

Expert Opinions

Managing Breast Cancer in 2015  

Will the PVS-RIPO Poliovirus Be a Game Changer in the Treatment of Recurrent Glioblastoma?  

The Mechanisms Driving Cancer Pain  

More Expert Opinions

Meeting News

Docetaxel Combined With Hormone Therapy Extends Survival in Advanced Prost... Novel Agent Elotuzumab Added to Lenalidomide/Dexamethasone Extends Progre... Simple Means of Preventing Nonmelanoma Skin Cancer Reported NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): 2015 Upd... More Meeting News

Journal Spotlight

ASCO Endorses American Cancer Society Prostate Cancer Survivorship Care G... Addition of Lenalidomide to Docetaxel-Prednisone Worsens Survival in Chemo... Higher-Than-Expected Incidence of Marrow Neoplasms After Adjuvant Therapy ... High Invasive Disease-Free Survival With Adjuvant Paclitaxel and Trastuzum... More Journal Spotlights

Health-Care Policy

ASCO, ACCC Respond to Repeal of Medicare Sustainable Growth Rate Formula Bombarded With Changes in Health Care and Beyond, Gynecologic Oncologists Prepare for the Challenges Ahead After Decades of Uncertainty, the Sustainable Growth Rate Formula Is Repealed by Congress Creating a Collective Path Forward to Optimize Value in Cancer Care More Health-care Policy

Drugs & Regimens

Pembrolizumab Safe and Effective in Patients With NSCLC, Especially in Those With Tumors Showing High Levels of PD-L1 Expression Many Miles to Go: Targeted Treatment Based on Whole-Genome Sequencing Adoptive T-Cell Therapy Successfully Treats Devastating Complication of Stem Cell Transplantation Prostate Tumors With Genetic Abnormalities Respond to Olaparib More Drugs & Regimens

Oncology Worldwide

Noncommunicable Diseases Are the Leading Cause of Death in Low- and Middle-Income Countries How the International Innovation Grant Is Improving Cancer Care for Women in Myanmar Global Oncology Launches Global Cancer Project Map With NCI Addressing the Global Cancer Burden More Oncology Worldwide

Patient's Corner

Living With a Rare Cancer—My Dr. Seuss World Cancer Has Left an Indelible Mark on Me Too Young to Have Cancer I Refuse to Capitulate to Cancer More Patient's Corner

More on Twitter